One Stop Solution For In-Depth Market Research Reports

詳細な市場調査レポートのワンストップソリューション

Home    >    HEALTHCARE AND PHARMACEUTICALS   >   Molecular Diagnostics Market

[ 英語タイトル ] Molecular Diagnostics Market by Application (Infectious Disease (Hepatitis, HIV), Oncology, Genetic Testing), Technology (PCR, DNA Sequencing & NGS), End User (Hospital/Academic Laboratory), Product & Service (Reagent, Software) - Global Forecast to 2023


Product Code : MNMHC00109826
Survey : MarketsandMarkets
Publish On : February, 2021
Category : Healthcare and Pharmaceuticals
Study Area : Global
Report format : PDF
Sales price option (consumption tax not included)
Single User USD5650 / Question Form
5 User USD6650 / Question Form
Enterprise User USD10000 / Question Form

[Report Description]

“The global molecular diagnostics market is projected to grow at a CAGR of 8.4%.”
The global molecular diagnostics market is expected to reach USD 11.54 billion by 2023 from USD 7.71 billion in 2018, at a CAGR of 8.4%. Growth in this market can primarily be attributed to the high prevalence of infectious diseases and various types of cancers, increasing awareness and acceptance of personalized medicine and companion diagnostics, growth in the biomarker identification market, and advancements in molecular techniques. However, complex regulatory frameworks delaying the approval of new molecular diagnostic tests are expected to restrain the growth of this market during the forecast period.
“The reagents & kits segment to dominate the molecular diagnostics market, by product & service in 2018.”
Based on product and service, the molecular diagnostics market is segmented into reagents and kits, instruments, and services and software. The reagents and kits segment is expected to account for the largest share of the global molecular diagnostics market in 2018. The large share of this segment can be attributed to the availability of a wide range of reagents and kits, rising use of reagents and kits in different therapeutic areas (such as infectious diseases and oncology), increase in basic research and commercial applications, and easy accessibility to a wide range of reagents.
“The market in the Asia Pacific region is projected to register the highest CAGR during the forecast period.”
Asia Pacific is expected to register the highest CAGR in the global molecular diagnostics market during the forecast period. Market growth in the Asia Pacific is attributed to growing GDPs and a significant rise in disposable income levels, increased healthcare spending by a larger population base, modernization of healthcare infrastructure, and rising penetration of cutting-edge clinical laboratory technologies (especially in rural areas).
Break-up profile of primaries:
• By Company Type - Tier I: 40%, Tier II: 30%, and Tier III: 30%
• By Designation - C-level: 27%, D-level: 18%, and Others: 55%
• By Region - North America: 50%, Europe: 20%, Asia Pacific: 20%, and the RoW: 10%
The key players operating in the global molecular diagnostics market are Roche (Switzerland), Hologic (US), QIAGEN (Netherlands), Abbott (US), and Danaher (US).
Research coverage:
In this report, the molecular diagnostics market is segmented on the basis of product & service, application, technology, end user, and region. The study tracks and analyzes competitive developments such as product launches & approvals, acquisitions, collaborations, agreements, partnerships, and expansions, and core competencies in the molecular diagnostics market.


Reasons to buy this report:
The report provides insights on the following pointers:
Market Penetration: Comprehensive information on portfolios offered by the top players in the global molecular diagnostics market. The report analyzes the market, by product & service, application, technology, end user, and region
Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and product launches in the global molecular diagnostics market
Market Development: Comprehensive information about lucrative emerging markets—the report analyzes the markets for molecular diagnostic products across regions
Market Diversification: Exhaustive information about new products, untapped regions, and recent developments in the global molecular diagnostics market
Competitive Assessment: In-depth assessment of strategies, products, and manufacturing capabilities of the key players in the global molecular diagnostics market

TABLE OF CONTENTS

1 INTRODUCTION 22
1.1 OBJECTIVES OF THE STUDY 22
1.2 MARKET DEFINITION 22
1.2.1 MARKETS COVERED 23
1.2.2 YEARS CONSIDERED FOR THE STUDY 24
1.3 CURRENCY 24
1.4 LIMITATIONS 24
1.5 STAKEHOLDERS 25
2 RESEARCH METHODOLOGY 26
2.1 PRIMARY DATA 27
2.1.1 KEY DATA FROM PRIMARY SOURCES 27
2.1.2 KEY INDUSTRY INSIGHTS 28
2.2 SECONDARY DATA 29
2.2.1 KEY DATA FROM SECONDARY SOURCES 29
2.3 MARKET SIZE ESTIMATION 30
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 32
2.4.1 ASSUMPTIONS FOR THE STUDY 33
3 EXECUTIVE SUMMARY 34
4 PREMIUM INSIGHTS 39
4.1 MOLECULAR DIAGNOSTICS: MARKET OVERVIEW 39
4.2 MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY AND REGION, 2018 40
4.3 MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT AND SERVICE,
2018 VS. 2023 (USD BILLION) 40
4.4 MOLECULAR DIAGNOSTICS MARKET, BY END USER 41
5 MARKET OVERVIEW 42
5.1 INTRODUCTION 42
5.2 MARKET DYNAMICS 42
5.2.1 DRIVERS 43
5.2.1.1 High prevalence of infectious diseases and various types of cancers 43
5.2.1.2 Increasing awareness and acceptance of personalized medicine
and companion diagnostics 43
5.2.1.3 Growth in the biomarker identification market and advancements
in molecular techniques 43
5.2.2 RESTRAINTS 44
5.2.2.1 Complex regulatory frameworks delaying the approval of new molecular diagnostic tests 44
5.2.3 OPPORTUNITIES 44
5.2.3.1 Advances in genomics and proteomics 44
5.2.3.2 Growth opportunities in emerging markets 45
5.2.4 CHALLENGES 46
5.2.4.1 Dearth of trained professionals limiting the appropriate use
of new molecular diagnostic technologies 46
6 MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE 47
6.1 INTRODUCTION 48
6.2 REAGENTS & KITS 48
6.3 INSTRUMENTS 51
6.4 SERVICES & SOFTWARE 54
7 MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY 58
7.1 INTRODUCTION 59
7.2 POLYMERASE CHAIN REACTION (PCR) 60
7.3 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY (INAAT) 63
7.4 DNA SEQUENCING & NEXT-GENERATION SEQUENCING (NGS) 66
7.5 IN SITU HYBRIDIZATION 69
7.6 DNA MICROARRAY 72
7.7 OTHER TECHNOLOGIES 74
8 MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION 78
8.1 INTRODUCTION 79
8.2 INFECTIOUS DISEASES 80
8.2.1 HEPATITIS 84
8.2.2 HIV 85
8.2.3 CT/NG 86
8.2.4 HAIS 87
8.2.5 HPV 88
8.2.6 TUBERCULOSIS 89
8.2.7 INFLUENZA 90
8.2.8 OTHER INFECTIOUS DISEASES 91
8.3 ONCOLOGY 92
8.3.1 BREAST CANCER 95
8.3.2 COLORECTAL CANCER 95
8.3.3 LUNG CANCER 96
8.3.4 PROSTATE CANCER 97
8.3.5 OTHER CANCERS 98
8.4 GENETIC TESTS 99
8.5 OTHER APPLICATIONS 102

9 MOLECULAR DIAGNOSTICS MARKET, BY END USER 105
9.1 INTRODUCTION 106
9.2 HOSPITAL & ACADEMIC LABORATORIES 107
9.3 REFERENCE LABORATORIES 110
9.4 OTHER END USERS 113
10 MOLECULAR DIAGNOSTICS MARKET, BY REGION 116
10.1 INTRODUCTION 117
10.2 NORTH AMERICA 118
10.2.1 US 121
10.2.2 CANADA 124
10.3 EUROPE 126
10.3.1 GERMANY 129
10.3.2 FRANCE 132
10.3.3 ITALY 134
10.3.4 SPAIN 136
10.3.5 UK 138
10.3.6 REST OF EUROPE 141
10.4 ASIA PACIFIC 143
10.4.1 JAPAN 147
10.4.2 CHINA 149
10.4.3 AUSTRALIA 152
10.4.4 INDIA 154
10.4.5 ROAPAC 156
10.5 REST OF THE WORLD 159
10.5.1 LATIN AMERICA 161
10.5.1.1 Brazil 163
10.5.1.2 Mexico 166
10.5.1.3 Rest of Latin America 168
10.5.2 MIDDLE EAST & AFRICA 170
11 COMPETITIVE LANDSCAPE 173
11.1 OVERVIEW 173
11.2 MARKET SHARE ANALYSIS 174
11.3 MOLECULAR DIAGNOSTICS MARKET COMPETITIVE SHARE ANALYSIS, BY APPLICATION 175
11.3.1 MARKET SHARE ANALYSIS FOR INFECTIOUS DISEASE APPLICATIONS 175
11.3.2 MOLECULAR DIAGNOSTICS MARKET SHARE ANALYSIS, BY TECHNOLOGY 176
11.3.2.1 POLYMERASE CHAIN REACTION (PCR) 176
11.3.2.2 DNA SEQUENCING AND NGS 176
11.3.2.3 IN SITU HYBRIDIZATION (ISH) 177

11.4 COMPETITIVE SITUATION AND TRENDS 177
11.4.1 NEW PRODUCT LAUNCHES AND APPROVALS, 2016–2018 177
11.4.2 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, 2016–2018 178
11.4.3 ACQUISITIONS AND MERGERS 179
11.4.4 EXPANSIONS 179
12 COMPANY PROFILES 180
Business Overview, Products Offered, Services Offered, Recent Developments, MnM View
12.1 ABBOTT LABORATORIES 180
12.2 AGILENT TECHNOLOGIES 184
12.3 BECTON, DICKINSON AND COMPANY 189
12.4 BIOMÉRIEUX SA 194
12.5 DANAHER CORPORATION 198
12.6 DIASORIN 203
12.7 GRIFOLS 207
12.8 HOLOGIC 210
12.9 ILLUMINA 213
12.10 QIAGEN 217
12.11 ROCHE DIAGNOSTICS 222
12.12 SIEMENS AG 226
12.13 THERMO FISHER SCIENTIFIC 229
*Details might not be captured in case of unlisted companies.
13 APPENDIX 234
13.1 DISCUSSION GUIDE 234
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 237
13.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 239
13.4 AVAILABLE CUSTOMIZATIONS 240
13.5 RELATED REPORTS 240
13.6 AUTHOR DETAILS 241

渋谷データカウント

渋谷データカウントは、最も信頼性が高く最新の調査分析レポートを確実に提供する経験豊富な調査専門家のグローバルチームが提供する、さまざまな業界のさまざまな市場調査レポートを提供する再販代理店です。

Recommended reports

+